These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8983523)

  • 1. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of chemiluminescence for assessing the physiological status of macrophages activated by pertussis preparations].
    Moskalenko EP; Tiukavkina SIu
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):54-6. PubMed ID: 10876851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
    Canthaboo C; Xing D; Corbel M
    Dev Biol Stand; 1999; 101():95-103. PubMed ID: 10566781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of pertussis preparations on primary culture of peritoneal macrophages and continuous human monocyte-like cell line U937].
    Tiukavkina SIu; Savis'ko AA; Kharseeva GG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):85-7. PubMed ID: 21604390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Bordetella pertussis on rosette-forming cells present in the peritoneal fluids of mice.
    Fishel CW; Pross SH; Klein TW
    J Reticuloendothel Soc; 1976 Feb; 19(2):97-108. PubMed ID: 177778
    [No Abstract]   [Full Text] [Related]  

  • 6. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on toxicity of Bordetella pertussis cultures and antigens.
    Spasojević V
    Dev Biol Stand; 1977; 34():197-205. PubMed ID: 190070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the biological properties of a cell-free pertussis preparation].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Shmeleva EI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):38-43. PubMed ID: 2888247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
    Khosravani A; Parker MC; Parton R; Coote J
    Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
    Hormozi K; Parton R; Coote J
    Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The action of pertussis vaccines and GMDP on the change in the enzymatic activity of macrophages from peritoneal exudate].
    Ermolova EV; Britsina MV; Ozeretskovskaia MN; Shepeleva IB; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):56-9. PubMed ID: 10876852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenicity and toxicity of soluble trichloroacetic acid precipitate from pertussis microbes and its fractions].
    Bazhanova IG; Gladkaia VI; Liashenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):128-32. PubMed ID: 202117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunologic reaction of Bordetella pertussis and leukocytic reaction in mice].
    Walecki H; Sitek K
    Med Dosw Mikrobiol; 1966; 18(2):111-5. PubMed ID: 4287625
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental relation between leukocytosis and other factors of Bordetella pertussis].
    Ruiz Puente J; Rivera Rivera D; González Pacheco M
    Salud Publica Mex; 1981; 23(6):613-20. PubMed ID: 6278659
    [No Abstract]   [Full Text] [Related]  

  • 19. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.